LPL and B-cell chronic lymphocytic leukemia: The same group has also reported that ADAM29 is more often expressed in patients with M-CLL and that patients with U-CLL and LPL expression had shorter disease-free survival and overall survival after treatment with chemotherapy compared to patients with M-CLL and/or ADAM29 expression (84).